Eric Morgen - 18 Feb 2025 Form 4/A - Amendment Insider Report for BioAge Labs, Inc. (BIOA)

Role
Chief Operating Officer, Director
Signature
/s/ Dov A. Goldstein as attorney-in-fact
Issuer symbol
BIOA
Transactions as of
18 Feb 2025
Net transactions value
$0
Form type
4/A - Amendment
Filing time
25 Feb 2025, 16:28:11 UTC
Date Of Original Report
20 Feb 2025
Previous filing
25 Sep 2024
Next filing
19 Feb 2026
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIOA Stock Option (Right to Buy) Award $0 +25,000 $0.000000 25,000 18 Feb 2025 Common Stock 25,000 $4.38 By Spouse F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on February 1, 2025, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.
F2 Represents an employee stock option directly held by the reporting person's spouse.

Remarks:

This Form 4 is being amended to report the grant of an employee stock option award to the reporting person's spouse on the transaction date. This option award was inadvertently omitted from the Form 4 filed on February 20, 2025 to report a stock option award made directly to the reporting person.